BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38785501)

  • 1. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
    Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
    Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression.
    Wu X; Wang Y; Chen C; Xue Y; Zheng S; Cai L
    Genet Res (Camb); 2022; 2022():5671562. PubMed ID: 35903462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
    Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
    J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
    Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
    Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
    Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
    Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
    Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
    PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Expression Profiling in Adrenal Myelolipoma.
    Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
    Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T
    Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
    Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment.
    Ornello R; Zelli V; Compagnoni C; Caponnetto V; De Matteis E; Tiseo C; Tessitore A; Sacco S
    J Headache Pain; 2024 May; 25(1):80. PubMed ID: 38755568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.
    Slattery ML; Herrick JS; Mullany LE; Valeri N; Stevens J; Caan BJ; Samowitz W; Wolff RK
    Int J Cancer; 2015 Jul; 137(2):428-38. PubMed ID: 25484364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.